Link: Finance – canada.com network.
Covalon Technologies Ltd. (TSX VENTURE:COV) is extremely pleased to announce that it has received a U.S.A. patent and a European Patent Certificate for its method of making silver ion-releasing anti-microbial coatings for implantable medical devices for reducing hospital acquired infections in patients.
Covalon has received U.S.A. and European patent protection for its technology in applying an anti-microbial, sustained silver ion-releasing coating/complex to wound dressings, skin surface coverings and implantable medical devices for deterring the onset of hospital acquired infections (HAI) in patients. The use of skin coverings and implanted medical devices are a vital component of clinical practice, however, complications may arise from their use. Complications include the potential of the device to become the focus of microbial contamination that may lead to an HAI in the patient.
